Shigekatsu Kohno

Title: Shigekatsu Kohno: Innovator in Anti-Asthmatic Solutions

Introduction

Shigekatsu Kohno is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing effective treatments for asthma. His innovative work has led to the creation of a unique anti-asthmatic composition that addresses critical health needs.

Latest Patents

Kohno holds a patent for an anti-asthmatic composition and the process for preparing it. The patent, titled "5-(3-n-Butyloxalylaminophenyl) tetrazole," showcases an excellent SRS-A release-inhibiting effect. This compound serves as an effective component for an anti-asthmatic agent. The pharmaceutical preparation, which combines the tetrazole with a specific dispersant such as polysorbate-80 in the presence of a non-aqueous solvent, demonstrates high solubility and bioavailability.

Career Highlights

Shigekatsu Kohno is associated with Wakamoto Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing treatments for respiratory conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Kohno has collaborated with notable colleagues, including Touru Oguma and Katsuya Ohata. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.

Conclusion

Shigekatsu Kohno's contributions to the field of anti-asthmatic treatments highlight his role as a key innovator in pharmaceuticals. His patented work not only addresses significant health challenges but also exemplifies the importance of innovation in improving quality of life for patients.